In response to DNA damage, ATM/ATR activate p53, resulting in either cell cycle arrest or apoptosis. We report here that DNA damage stimuli, including etoposide (ETOP), adriamycin (ADR), ionizing irradiation (IR), and ultraviolet irradiation (UV) activate Erk1/2 (Erk) mitogen Taken together, these results indicate that DNA damage activates parallel Erk and p53 pathways in an ATM dependent manner. These pathways might function cooperatively in cell cycle arrest and apoptosis.
Introduction
Eukaryotic cells employ multiple mechanisms to ensure accurate transmission of genetic information between generations. Critical surveillance of this transmission is provided by the DNA damage response, which may arrest the cell cycle to allow damage repair, or direct cells to apoptosis in situations of severe damage 1-4 .
Our understanding of how cells sense DNA damage remains incomplete, but it is clear that two members of the phosphatidylinositol-3 (PI-3) kinase family, ATM and ATR, are major DNA damage signal transducers 4 . Downstream of ATM/ATR lies p53, a central mediator of the response, which in turn induces cell cycle arrest by up-regulation of p21 CIP1 and 14-3-3σ , activates DNA damage repair pathways, and induces apoptosis 5;6 . p53 is normally rapidly degraded by Mdm2-mediated ubiquitin-dependent proteolysis 7;8 . In response to DNA damage, p53 is stabilized by inhibition of this proteolytic process, partly through post-translational phosphorylation. Stabilization of p53 by phosphorylation on residues S15 and S21 by ATM and Chk2 kinase in response to DNA damage is well-described 9-11 . Members of the mitogen activated protein kinase (MAPK) family have also been demonstrated to phosphorylate and stabilize p53 12-14 . To wit, activation of JNK leads to p53 phosphorylation, thus interfering with the association of Mdm2 and p53 12 . Furthermore, activation of p38 MAPK by UV was shown to phosphorylate p53 on S389 13;14 .
The third member of the canonical MAPK family, Erk (extracellular-signal-regulated kinase), is centered on multiple signal transduction pathways to accomplish a variety of functions. Activation of Erk through different pathways leads to fundamentally different cellular responses, including proliferation, differentiation, survival, and memory consolidation 15-19 . Erk activation by extracellular growth signals is mediated through growth factor tyrosine phosphorylation and activation of a small G protein, Ras, and promotes cell proliferation 20;21 .
The importance of Erk in transduction of mitogenic signals is illustrated by the demonstration that activation of Erk is sufficient to transform NIH3T3 cells or MEF lacking either p53 or p16 22;23 . In some circumstances, ligand interactions with growth factor receptors may result in Erkmediated cell cycle exit. Indeed, Erk activation by nerve growth factor (NGF) drives PC12 cell differentiation 22;24 . Erk may function in the response to DNA damage. Erk activation was observed in response to cisplatin in ovarian cancer cells 25 . Erk can phosphorylate p53 in vitro 25 , but its role in vivo is unclear [25] [26] [27] . The role of DNA damage-induced Erk activation in mediating apoptosis has also not been clarified 28;29 . In this regard, however, tumors with constitutive Erk activation undergo apoptosis when Erk activity is blocked 30 .
Consequently, we sought to explore Erk activation in response to DNA damage, and to outline the mechanisms and consequences of such activation. We report here that multiple DNA damage stimuli, including etoposide (ETOP), adriamycin (ADR), ultraviolet irradiation (UV) and ionizing radiation (IR) activate Erk in various cell lines. We show that this process depends on ATM and is independent of p53. Functionally, we demonstrate that Erk activation cooperates with p53 to lead to apoptosis or cell cycle arrest. This represents the first report to fully outline an Erk-mediated DNA damage pathway and its functional importance.
Materials and Methods

Materials, cell lines, and plasmids.
Hoechst 33258, Propidium iodide (PI), ETOP, ADR, HU, and wortmannin were from Sigma. The MEK1 inhibitors, PD98059 and U0126 were from Calbiochem and Promega, respectively. Stocks of ETOP, ADR, wortmannin, PD98059, and U0126 were made in DMSO and used at the concentrations indicated. Hygromycin B was from GIBCO BRL.
NIH3T3 and MCF7 cells were cultured in DMEM supplemented with 10% fetal calf serum (Gibco BRL) at 37 0 C in a tissue culture incubator. MEF were isolated and cultured in DMEM, 10% FCS, 55µM β-mercaptoethanol and 10µg/ml gentamycin. IMR-90 was from ATCC and cultured in MEM and 10% FCS. The AT fibroblast line, GM05823, was from NIGMS Human Genetic Cell Repository and cultured in MEM, 10% FCS (uninactivated), with 2X concentrated essential and non-essential amino acids and vitamins.
The constitutively activated MEK1/Q56P cloned in the retroviral vector, pBabe, was kindly provided by Dr. Scott Lowe of Cold Spring Harbor Laboratories 23 . pBabe/Bcl-2 and pBabe/Bcl-x L were constructed by insertion of human Bcl-2 and Bcl-x L into pBabe as we have published 31 .
Retroviral Infection
Retroviral infection was performed as we have published 31;32 . Constructs were subcloned into a retroviral vector. Plasmid DNA was isolated and used to generate retrovirus using phoenix packing cells. Briefly, 5x10 6 phoenix cells were seeded in a 10 cm plate overnight before transfection with 15 µg retroviral vector for 48 hours. The virus-containing medium was harvested after 48 hours and filtered through a 0.45 µM filter. After addition of 10 µg/ml of polybrene (Sigma), the medium was used to infect NIH3T3 cells three times for 24 hours at 8 hour intervals to maximize transfection rate. Expression was confirmed with western blot.
Cell lysis and western blot.
After exposure to DNA damage agents as indicated, cells were lysed in a buffer containing 20mM Tris (pH 7.4), 150mM NaCl, 1mM EDTA, 1mM EGTA, 1% Triton X-100, 25mM soduim pyrophosphate, 1mM NaF, 1mM β-glycerophosphate, 0.1mM sodium orthovanadate, 1mM PMSF, 2µg/ml leupeptin and 10µg/ml aprotinin. 50µg of total cell lysate was separated on SDS-PAGE gel and transferred onto Immobilon-P membranes (Millipore).
Membranes were blocked with 5% skim milk and then incubated with the indicated antibodies at room temperature for 1 hour. Signals were detected using an ECL Western Blotting Kit (Amersham). Primary antibodies and concentration used were: anti-ATM (Ab-3 at 2µg/ml, Oncogene); anti-p53 (FL-353 at 1µg/ml, Santa Cruz); anti-phospho-p53(S15) (Cell Signaling, 1:1000); anti-Erk (1:500, New England Biolabs); anti-phospho-Erk (1:500 New England Biolabs); anti-Actin (Santa Cruz); anti-p21 CIP1 (1µg/ml, Santa Cruz). 
Mitotic Index
Cells were grown to 80% confluence on a glass slip. After treatment with ETOP at the indicated concentrations for 30 minutes, nocodazole (200ng/ml) was added. After 12, 18, 24 and 30 hours cells were fixed in 3.7% formaldehyde and stored at 4 0 C for 24 hours. Cells were then permeabilized in a Triton X-100 containing solution and stained with Hoechst 33258 DNA stain (10µg/ml; Molecular Probes). The mitotic index was scored under a fluorescent microscope. and up-regulation of p21 CIP1 (Fig. 2) . S15 phosphorylation-associated p53 stabilization was significantly reduced and p21 CIP1 induction was abolished in GM05823 cells in response to ADR or ETOP (Fig. 2) , further confirming the lack of ATM function in the ATM-/-fibroblasts.
Results
Multiple
Importantly, ETOP induced Erk activation was absent in GM05823 but present in IMR90 (Fig.   2) , confirming a role of ATM in ETOP induced Erk activation. However, ADR induced Erk activation was not attenuated in the ATM-/-fibroblast line (Fig 2) , suggesting that ATR might also play an important role in this setting. Caffeine (2mM), which inhibits both ATM and ATR 41 did prevent ADR induced Erk activation in this context, supporting the supposition that ATR plays a role in the transmission of ADR mediated DNA damage to Erk (data not shown).
DNA damage induced Erk activation is independent of p53. Since p53 is the major effector protein downstream of ATM mediating the DNA damage response, we sought to investigate if Erk activation played a role in the p53 pathway, as has been suggested by others 25-27 . Kinetically, p53 stabilization by ETOP (Fig 3A) , ADR and IR (data not shown) preceded Erk activation in all cell lines studied. Fig 3A shows MCF-7 cells. MEK1 inhibition with PD98059 inhibited Erk activation but was without effect on p53 stabilization in response to DNA damage in MEF, NIH3T3 and MCF-7 cells ( Fig. 3B; NIH3T3 ), suggesting that Erk activation was not upstream of p53. Conversely, pre-treatment of cells with cycloheximide (CHX) for 30 minutes to destroy endogenous p53 prevented ETOP (data not shown) and ADR ( Fig.3C; activation is slightly lower in MEF p53-/-due to higher basal level of Erk activity in these p53 negative cells (Fig 3D) . ADR and UV also induced Erk activation in MEF p53-/-(data not shown). Taken together, these data indicate quite conclusively that under physiologic conditions, DNA damage-induced Erk activation is independent of p53.
Erk activation maximizes p21 CIP1 induction upon DNA damage. The two paradigmatic cellular responses to DNA damage are cell cycle arrest (allowing the damage to be repaired) or apoptosis in response to low or high intensities of DNA damage respectively. The Cdk inhibitor, p21 CIP1 is up-regulated in this process, and plays a major role in arresting cells in either G1 or at G2/M in response to DNA damage 42;43 . We have observed that wortmannin affected Erk activation and p21 CIP1 induction in a more clearly dose dependent manner than p53 stabilization after DNA damage (data not shown), suggesting that Erk activation might up-regulate p21 CIP1 . This is consistent with the observations that enforced Erk activation by over-expression of a constitutively activated Raf1 led to p21 CIP1 induction 44;45 .
Consequently, we examined the effect of inhibition of Erk activation on p21 CIP1 induction after DNA damage. Inhibition of Erk activation by PD98059 reduced p21 CIP1 induction by half ( Fig. 3B and 4 ) but had no effect on p53 stabilization by ETOP (Fig. 3B ).
PD98059 also attenuated ADR induced p21 CIP1 induction (Fig. 4) . As expected, overexpression of a constitutively activated MEK1/Q56P 23 strongly activated Erk in NIH3T3 and MEF cells (data not shown) and led to p21 CIP1 induction that was also inhibited by PD98059 (Fig. 4) . Further, expression of MEK1/Q56P in MEF p53-/-cells also resulted in p21 CIP1 induction (data not shown), indicating that Erk activation is capable of inducing p21 CIP1 expression, consistent with prior observations with forcibly expressed Raf1 44;45 . Our data, though, is the first to demonstrate p21 CIP1 induction by Erk under physiologic conditions. Erk activation is required for cell cycle arrest upon DNA damage. As Erk activation partially contributes to p21 CIP1 induction ( Fig.3B and 4) , and p21 CIP1 plays an important role in both induction of G 1 arrest 43 and maintenance of arrest at the G 2 /M checkpoint 42 , we sought to determine whether the magnitude of p21 CIP1 induction induced by Erk activation played a functional role in cell cycle arrest in response to DNA damage. Whilst PD98059 100µM alone results a degree of G 1 arrest (Fig 5B) , consistent with the notion that ERK activity facilitates G 1 progression 46 , addition of PD98059 to ETOP 0.5µM (Fig 5D) led to a marked release from the G 2 /M arrest seen with etoposide 0.5µM alone (Fig 5C) . We confirmed that G 2 /M release was indeed occurring by mitotic labeling with nocodazole trapping and showed an increase of mitotic cells from 5 to 11% at 24h when PD98059 is added to ETOP 0.5µM (data not shown). To further confirm a role of Erk in maintaining G2/M arrest in response to ETOP, a more specific MEK1 inhibitor, U0126, was also used. While 50µM U0126 alone has a minimal effect on G1 phase (Fig 5 E) , 10µM and 50µM U0126 again dramatically released ETOP (0.5µM) induced G2/M arrest (Fig. 5 E) . Similar results were observed with ADR (data not shown), although the effect of PD98059 on cell cycle arrest induced by ADR is less prominent than that induced by ETOP, consistent with the observation that inhibition of Erk activation was more effective in preventing ETOP-than ADR-mediated p21 CIP1 induction (Fig. 4) . (Fig 6A) . Overexpression of the anti-apoptotic proteins Bcl-2 or Bcl-x L also prevented apoptosis in response to ETOP, indicating that the mitochondrial cellular execution pathway plays a role in DNA damage-induced apoptosis (Fig 6A) . Quantification of apoptosis using terminal deoxyuridine end-nick labeling (TUNEL) revealed that 65% of cells were apoptotic when exposed to 10µM ETOP for 24 hours, and that ERK inhibition with PD 98059 dose-dependently reduced this to less than 10%, suggesting a major role for ERK in DNA damage induced apoptosis in response to ETOP (Fig 6B) . Similarly, Bcl-2 or Bcl-x L overexpression also reduced apoptosis to approximately 10%, indicating again the importance of the mitochondrial execution pathway (Fig 6B) . Identical results were also obtained when U0126 was used. While U0126 alone at 50µM induced no apoptosis, addition of 10µM and 50µM strongly inhibited 10µM ETOP induced apoptosis (Fig 7) . When TUNEL was used to quantify apoptotic cells in (Fig 8) . Inhibition of MEK-1 with PD98059 again essentially prevented this (Fig 8) .
Erk activation facilitates
Since our data indicated that Erk was activated by a number of DNA damage stimuli (Fig. 1B) , we sought to ensure that pro-apoptotic signaling through ERK was a general response to DNA damage. Consequently, the effect of PD98059 on UV and ADR induced cell death were also examined. Inhibition of Erk activation by PD98059 increased cell survival in response to both UV and ADR treatments ( Fig. 9A and B) . Taken together, these results show that Erk activation facilitates DNA damage induced apoptosis. Lack of a functional ATM kinase, the best characterized transducer of DNA damage, is also characterized by chromosomal instability in response to DNA damage and the development of cancer 51;52 .
In this paper, we add novel information to an already very complex DNA damage response. We initially observed that DNA damage agents were able to initiate Erk activation as measured by Erk phosphorylation in several cell lines (Fig. 1) Since p53 protein is a major effector in the DNA damage response, it is essential to determine any linkage between p53 and Erk activation after DNA damage. Like other oncogenic signals, Erk activation leads to p14 ARF dependent p53 activation in primary but not immortalized MEF 23;58-61 . In the case of DNA damage response, however, we have found that Erk activation occurs independently of p53. This is based on following observations: 1) the MEK1 inhibitor, PD98059, prevented Erk activation but not p53 stabilization in response to DNA damage (Fig. 3B) and 2 ) pre-incubation with CHX at 10µg/ml for 30 minutes to destroy endogenous p53 completely blocked DNA damage induced p53 stabilization but not Erk activation (Fig. 3C) and 3 ) the maximal level of Erk activation by UV, ETOP, and ADR was not attenuated in MEF p53-/- (Fig 3D) . This is consistent with the observation that enforced activation of Erk leads to cell cycle arrest in a p53 independent manner (our unpublished observations) 44;45 .
Our results are different from reports that Erk activation lies either upstream or downstream of p53 in response to various DNA damage agents. Inhibition of Erk activation by PD98059 was found to prevent cisplatin-induced p53 stabilization by reducing phosphorylation of S15 in the N-terminal region of p53 25 . Although it was not clearly demonstrated, the authors indicated that by interaction with p53, Erk phosphorylated p53 on S15. It is unclear how Erk, a proline directed kinase, could phosphorylate S15 of p53 since this residue is not followed by a proline, but rather a Q residue. Further, cisplatin induced Erk activation could be inhibited by suramin, a growth factor receptor antagonist, suggesting that Erk activation might not be related to cisplatin-induced DNA damage 29 . However, the possibility remains that these observations may be due to the different DNA damage stimuli used. This is supported by data indicating that mitomycin C and actinomycin D-induced Erk activation was abolished in a p53 defective tumor cell line 26 , although in this case p53 would be placed upstream of Erk activation.
In support of the notion that p53 is required for some forms of DNA damage-induced 18 by guest on September 1, 2017 http://www.jbc.org/ Downloaded from Erk activation, Lee at al. 26 showed that over-expression of wild type p53 itself led to Erk activation. An alternative explanation for this is that over-expression of p53 leads to feedback activation of a DNA damage response pathway, resulting in ATM kinase activation. ATM kinase in turn leads to Erk activation, consistent with our observation that Erk activation depends on ATM after DNA damage. Supporting this inference was the observation that over-expression of wild type p53 led to activation of p53 26 . However, it is known that simply increasing the abundance of p53 is insufficient to activate p53 pathway 62 .
Although independent of p53, our data shows that Erk activation makes important contributions to functional outcomes-cell cycle arrest and apoptosis-after DNA damage.
Inhibition of Erk activation by PD98059 or U0126 (data not shown) diminished p21 CIP1 induction, explaining the partial release by these inhibitors from cell cycle arrest in response to low concentrations of either ETOP (Fig 5) or ADR (data not shown), since p21 CIP1 is required to maintain G2/M arrest 42 . Although enforced activation of Erk is known to lead to p21 CIP1 induction in a p53 independent manner 44;45 , our demonstration here is the first that Erk activation contributes to the induction of p21 CIP1 under physiologic conditions. In response to higher doses of ETOP, ADR, and UV, inhibition of Erk activation by PD98059 and U0126 attenuated apoptosis (Figs.6 and 7) . Since DNA damage-induced cell cycle arrest and apoptosis requires p53, our results indicate the existence of a parallel Erk dependent pathway also functional in DNA damage-induced cell cycle arrest and apoptosis.
The data presented here demonstrate that Erk activation after DNA damage plays a Western blot was carried out to determine p53 stabilization with an anti-p53 antibody, phosphorylation on the S15 of p53 with anti-phospho-p53(S15), up-regulation of P21 CIP1 with anti-p21 CIP1 , and Erk activation with an anti-phospho-Erk antibody. Blots were routinely reprobed with an anti-actin antibody to control for loading. All experiments were performed at least in triplicate, and representative radiographs shown. 
